Tsai S L, Chen M H, Yeh C T, Chu C M, Lin A N, Chiou F H, Chang T H, Liaw Y F
Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung Medical College, Taipei, Taiwan.
J Clin Invest. 1996 Jan 15;97(2):577-84. doi: 10.1172/JCI118450.
In vitro studies in patients with hepatitis B virus (HBV) infection have suggested that hepatocytolysis induced by CD8+ cytotoxic T lymphocytes (CTLs) is the most important effector pathway in eliminating infected cells. The recognition is implicated in the endogenously processed HBV antigens in the context of HLA class I molecules presented on the liver cell membrane. However, the naturally occurring HBV peptide antigens have not yet been demonstrated. We report here that a naturally processed peptide antigen P2 was isolated from HLA class I molecules of HBV-infected liver cell membrane. The P2 peptide exhibited the activity of sensitizing target cells for lysis by CD8+ CTLs. The P2 sequence (YVNVNMGLK) purified from liver tissue was in concordance with that encoded by the viral genome for the HBV nucleocapsid antigen or HBcAg 88-96. P2 peptide could also be isolated from the EBV-transformed B cells that were transfected by HBcAg-expressing vector. The P2 epitope, sharing the HLA-A11 binding motifs, was recognized by HLA-A11-restricted CD8+ CTLs. The data provided direct evidence that, in hepatitis B patients, antigenic peptides of HBV were processed by hepatocytes, presented with the class I MHC molecules, and recognized by CD8+ CTLs.
对乙型肝炎病毒(HBV)感染患者的体外研究表明,CD8 + 细胞毒性T淋巴细胞(CTL)诱导的肝细胞溶解是消除受感染细胞的最重要效应途径。这种识别与肝细胞细胞膜上呈递的HLA I类分子背景下内源性加工的HBV抗原有关。然而,尚未证实天然存在的HBV肽抗原。我们在此报告,从HBV感染的肝细胞细胞膜的HLA I类分子中分离出一种天然加工的肽抗原P2。P2肽表现出使靶细胞对CD8 + CTL裂解敏感的活性。从肝组织中纯化的P2序列(YVNVNMGLK)与HBV核衣壳抗原或HBcAg 88 - 96的病毒基因组编码序列一致。P2肽也可以从表达HBcAg的载体转染的EBV转化的B细胞中分离出来。与HLA - A11结合基序相同的P2表位被HLA - A11限制性CD8 + CTL识别。这些数据提供了直接证据,表明在乙型肝炎患者中,HBV的抗原肽由肝细胞加工,与I类MHC分子呈递,并被CD8 + CTL识别。